Morgan Stanley’s AXS Cannabis ETF THCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-872
| Closed | -$14.7K | – | 8072 |
|
|
2023
Q4 | $14.7K | Buy |
872
+124
| +17% | +$2.06K | ﹤0.01% | 6744 |
|
|
2023
Q3 | $13.9K | Sell |
748
-66
| -8% | -$1.22K | ﹤0.01% | 6604 |
|
|
2023
Q2 | $13.9K | Hold |
814
| – | – | ﹤0.01% | 6683 |
|
|
2023
Q1 | $17.5K | Sell |
814
-1
| -0.1% | -$25 | ﹤0.01% | 6673 |
|
|
2022
Q4 | $21.1K | Sell |
815
-200
| -20% | -$5.96K | ﹤0.01% | 6678 |
|
|
2022
Q3 | $29K | Buy |
1,015
+31
| +3% | +$1.14K | ﹤0.01% | 6642 |
|
|
2022
Q2 | $37K | Sell |
984
-223
| -18% | -$11.7K | ﹤0.01% | 6754 |
|
|
2022
Q1 | $92K | Buy |
1,207
+232
| +24% | +$17.2K | ﹤0.01% | 6361 |
|
|
2021
Q4 | $83K | Buy |
975
+238
| +32% | +$26.1K | ﹤0.01% | 6547 |
|
|
2021
Q3 | $95K | Buy |
737
+50
| +7% | +$7.35K | ﹤0.01% | 6410 |
|
|
2021
Q2 | $118K | Buy |
687
+6
| +0.9% | +$1.05K | ﹤0.01% | 6281 |
|
|
2021
Q1 | $134K | Buy |
+681
| New | +$133K | ﹤0.01% | 5869 |
|
Morgan Stanley's THCX Position: Q1 2024 in Review
Morgan Stanley sold out of AXS Cannabis ETF (THCX) in Q1 2024, closing a stake of 872 shares — an estimated $14.7K sold.
Morgan Stanley first reported a position in THCX in Q1 2021 and held it in 12 quarters. The position peaked at $134K in Q1 2021. 0 funds tracked by Wall St. Rank hold THCX as of Q1 2024.
- Morgan Stanley reported no remaining AXS Cannabis ETF position as of Q1 2024 after selling out during the quarter.
- Morgan Stanley sold 872 AXS Cannabis ETF shares in Q1 2024, an estimated $14.7K.
- Morgan Stanley first reported a position in AXS Cannabis ETF in Q1 2021 and held it in 12 quarters.
- Morgan Stanley's AXS Cannabis ETF position peaked at $134K in Q1 2021.
- 0 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q1 2024.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.